latest newsHalf Yearly Results Half Year Report and Accounts Shareholder Update February 2010 Appendix 4C Quarterly Report BioDiem regains Japanese Rights Extension of Co-operative Research Development Agreement WHO issues a further sublicence of LAIV Appendix 4C Quarterly Report LAIV Proof of Concept Trial Results of AGM AGM Presentation Chairman's Address to Shareholders WHO Sub-licenses BDM's LAIV Technology Agreement with PATH for Prototype Pandemic Influenza Vaccine Completion of Phase I Clinical Trial Recruitment for LAIV Notice of Meeting & Proxy Form Annual Report - Complete Annual Report - Chairman's Review Annual Report - Editorial Annual Report - Financials | Investor InformationASX Announcements Financial Results
| ASX Link
|